Understanding human variation in infectious disease susceptibility through clinical and cellular GWAS - PubMed (original) (raw)

Review

Understanding human variation in infectious disease susceptibility through clinical and cellular GWAS

Dennis C Ko et al. PLoS Pathog. 2013.

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1

Figure 1. GWAS of varying phenotypic scales.

GWAS have primarily been used to characterize disease-related characteristics in patient populations, but new approaches have expanded the phenotypes used in GWAS. “Clinical GWAS” search for associations between genetic differences (primarily in the form of SNPs) and human disease traits such as disease risk, severity of disease, disease progression, and response to treatment. “Molecular GWAS” search for associations between SNPs and molecular phenotypes such as levels of mRNAs, proteins, or metabolites. Finally, “cellular GWAS” connect SNPs to particular cellular processes. Phenotypic variation in these cellular processes can be examined by manipulation either pharmacologically or using pathogens.

Similar articles

Cited by

References

    1. Raychaudhuri S (2011) Mapping rare and common causal alleles for complex human diseases. Cell 147: 57–69. - PMC - PubMed
    1. Allison AC (1954) Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J 1: 290–294. - PMC - PubMed
    1. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273: 1856–1862. - PubMed
    1. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119–124. - PMC - PubMed
    1. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599–603. - PubMed

Publication types

MeSH terms

LinkOut - more resources